Renaissance Technologies’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-129,524
| Closed | -$286K | – | 4269 |
|
|
2023
Q2 | $286K | Sell |
129,524
-112,600
| -47% | -$234K | ﹤0.01% | 3148 |
|
|
2023
Q1 | $615K | Sell |
242,124
-1,400
| -0.6% | -$2.77K | ﹤0.01% | 2775 |
|
|
2022
Q4 | $455K | Buy |
243,524
+14,700
| +6% | +$36.6K | ﹤0.01% | 3000 |
|
|
2022
Q3 | $588K | Sell |
228,824
-67,852
| -23% | -$169K | ﹤0.01% | 2831 |
|
|
2022
Q2 | $573K | Buy |
296,676
+123,252
| +71% | +$269K | ﹤0.01% | 3082 |
|
|
2022
Q1 | $515K | Buy |
173,424
+134,800
| +349% | +$507K | ﹤0.01% | 3174 |
|
|
2021
Q4 | $173K | Sell |
38,624
-163,000
| -81% | -$773K | ﹤0.01% | 3563 |
|
|
2021
Q3 | $980K | Sell |
201,624
-226,800
| -53% | -$1.25M | ﹤0.01% | 2563 |
|
|
2021
Q2 | $2.92M | Sell |
428,424
-175,396
| -29% | -$1.42M | ﹤0.01% | 1997 |
|
|
2021
Q1 | $4.26M | Sell |
603,820
-157,400
| -21% | -$1.13M | 0.01% | 1747 |
|
|
2020
Q4 | $4.76M | Buy |
761,220
+219,800
| +41% | +$1.29M | 0.01% | 1620 |
|
|
2020
Q3 | $2.93M | Buy |
541,420
+70,912
| +15% | +$351K | ﹤0.01% | 1893 |
|
|
2020
Q2 | $2.46M | Buy |
+470,508
| New | +$2.09M | ﹤0.01% | 2077 |
|
|
2019
Q3 | – | Sell |
-125,149
| Closed | -$499K | – | 3798 |
|
|
2019
Q2 | $499K | Sell |
125,149
-162,700
| -57% | -$774K | ﹤0.01% | 2997 |
|
|
2019
Q1 | $1.54M | Sell |
287,849
-58,321
| -17% | -$377K | ﹤0.01% | 2451 |
|
|
2018
Q4 | $1.78M | Buy |
346,170
+129,321
| +60% | +$982K | ﹤0.01% | 2298 |
|
|
2018
Q3 | $2.1M | Sell |
216,849
-323,100
| -60% | -$3.26M | ﹤0.01% | 2244 |
|
|
2018
Q2 | $5.51M | Sell |
539,949
-30,900
| -5% | -$350K | 0.01% | 1722 |
|
|
2018
Q1 | $7.42M | Buy |
570,849
+120,200
| +27% | +$1.79M | 0.01% | 1565 |
|
|
2017
Q4 | $8.07M | Buy |
450,649
+79,911
| +22% | +$1.67M | 0.01% | 1508 |
|
|
2017
Q3 | $9.31M | Sell |
370,738
-226,011
| -38% | -$5.26M | 0.01% | 1379 |
|
|
2017
Q2 | $14.4M | Buy |
596,749
+182,236
| +44% | +$4.03M | 0.02% | 1040 |
|
|
2017
Q1 | $7.98M | Buy |
414,513
+304,249
| +276% | +$4.79M | 0.01% | 1391 |
|
|
2016
Q4 | $1.7M | Sell |
110,264
-33,249
| -23% | -$432K | ﹤0.01% | 2300 |
|
|
2016
Q3 | $1.87M | Buy |
143,513
+41,249
| +40% | +$547K | ﹤0.01% | 2231 |
|
|
2016
Q2 | $1.42M | Buy |
102,264
+23,700
| +30% | +$349K | ﹤0.01% | 2380 |
|
|
2016
Q1 | $1.19M | Sell |
78,564
-5,249
| -6% | -$80.3K | ﹤0.01% | 2496 |
|
|
2015
Q4 | $1.59M | Sell |
83,813
-15,000
| -15% | -$286K | ﹤0.01% | 2247 |
|
|
2015
Q3 | $1.88M | Sell |
98,813
-5,273
| -5% | -$131K | ﹤0.01% | 2037 |
|
|
2015
Q2 | $2.68M | Buy |
104,086
+64,622
| +164% | +$1.83M | 0.01% | 1860 |
|
|
2015
Q1 | $1.23M | Buy |
39,464
+16,100
| +69% | +$462K | ﹤0.01% | 2196 |
|
|
2014
Q4 | $901K | Sell |
23,364
-1,098
| -4% | -$26.2K | ﹤0.01% | 2172 |
|
|
2014
Q3 | $594K | Buy |
24,462
+5,475
| +29% | +$143K | ﹤0.01% | 2251 |
|
|
2014
Q2 | $453K | Buy |
18,987
+11,570
| +156% | +$377K | ﹤0.01% | 2362 |
|
|
2014
Q1 | $274K | Buy |
7,417
+1,159
| +19% | +$45.8K | ﹤0.01% | 2540 |
|
|
2013
Q4 | $252K | Sell |
6,258
-2,759
| -31% | -$117K | ﹤0.01% | 2554 |
|
|
2013
Q3 | $344K | Buy |
9,017
+2,175
| +32% | +$77.9K | ﹤0.01% | 2427 |
|
|
2013
Q2 | $248K | Buy |
+6,842
| New | +$293K | ﹤0.01% | 2467 |
|
Renaissance Technologies's PRTK Position: Q3 2023 in Review
Renaissance Technologies sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2023, closing a stake of 129,524 shares — an estimated $286K sold.
Renaissance Technologies first reported a position in PRTK in Q2 2013 and held it in 38 quarters. The position peaked at $14.4M in Q2 2017. 0 funds tracked by Wall St. Rank hold PRTK as of Q3 2023.
- Renaissance Technologies reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
- Renaissance Technologies sold 129,524 Paratek Pharmaceuticals, Inc. shares in Q3 2023, an estimated $286K.
- Renaissance Technologies first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2013 and held it in 38 quarters.
- Renaissance Technologies's Paratek Pharmaceuticals, Inc. position peaked at $14.4M in Q2 2017.
- 0 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2023.
Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.